Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantInflammationSystemic Inflammatory Response SyndromeCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalCytokinesSurvival AnalysisBreast NeoplasmsInflammation MediatorsEtoposideNeoplasm StagingPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMice, Inbred C57BLLipopolysaccharidesMethotrexateTumor Necrosis Factor-alphaTime FactorsCarboplatinPaclitaxelInterleukin-6Induction ChemotherapyVinblastineNeutrophilsNeoplasm Recurrence, LocalTaxoidsBleomycinNeoplasmsDisease Models, AnimalMacrophagesIfosfamideDrug Resistance, NeoplasmNF-kappa BLungDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticMice, KnockoutInterleukin-8Follow-Up StudiesAnthracyclinesSignal TransductionAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineDose-Response Relationship, DrugAnti-Inflammatory AgentsCells, CulturedSalvage TherapyCarcinoma, Non-Small-Cell LungProspective StudiesNeoplasm MetastasisOvarian NeoplasmsAdenocarcinomaInterleukin-1betaSepsisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousColorectal NeoplasmsToll-Like Receptor 4NauseaLymphoma, Non-HodgkinApoptosisAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseChemokinesLeukocyte CountRNA, MessengerImmunohistochemistryGranulocyte Colony-Stimulating FactorPneumoniaLeukocytesImmunity, InnateRadiotherapyNeutrophil InfiltrationAntibiotics, AntineoplasticMice, Inbred BALB CClinical Trials as TopicCell Line, TumorLeukopeniaDacarbazineReverse Transcriptase Polymerase Chain ReactionKaplan-Meier EstimateDisease ProgressionNeoplasms, Germ Cell and EmbryonalCarmustineLomustineBrain Neoplasms